Financials

News Ideas Minds Technicals

GYRE fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Gyre Therapeutics, Inc.

Total assets of GYRE for Q3 23 is 9.96 M USD, 19.61% less than the previous Q2 23. And total liabilities decreased by 12.87% in Q3 23 to 6.45 M USD.

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—